Evidence map›Paper›PMID 18670905›Full record

ArticleMolecular biology reports2009

Post-synthetic acetylation of HMGB1 protein modulates its interactions with supercoiled DNA.

Iva Ugrinova, Iliya G Pashev, Evdokia A Pasheva

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Paeonol attenuates inflammation by confining HMGB1 to the nucleus.Journal of cellular and molecular medicine · 2021
    Article
  2. Functional Diversity of Non-Histone Chromosomal Protein HmgB1.International journal of molecular sciences · 2020
    Review
  3. Article
  4. High-Mobility Group Box-1 and Liver Disease.Hepatology communications · 2018
    Review
  5. Article
  6. The Functional Analysis of Histone Acetyltransferase MOF in Tumorigenesis.International journal of molecular sciences · 2016
    Review
  7. Histone and Non-Histone Targets of Dietary Deacetylase Inhibitors.Current topics in medicinal chemistry · 2016
    Review
  8. Article
  9. Article
  10. Article
  11. HMG modifications and nuclear function.Biochimica et biophysica acta
    Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Iva UgrinovaInstitute of Molecular biology, Bulgarian Academy of Sciences, 1113, Sofia, Bulgaria.
Iliya G Pashev
Evdokia A Pasheva
Bulgarian Academy of Sciences · BGInstitute of Molecular Biology · BG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High mobility group box (HMGB) proteins 1 and 2 are abundant non-histone nuclear proteins that regulate chromatin structure because of their structure-specific binding to DNA. Here, we have investigated how the post-synthetic acetylation of HMGB1 affects its interaction with negatively supercoiled DNA by employing monoacetylated at Lys2 protein, isolated from butyrate-treated cells. Our data reveal that this modification enhances three reaction parameters: binding affinity, supercoiling activity and capacity to protect the supercoiled DNA from relaxation by topoisomerase I. We show that monoacetylation at Lys2 mimics the effect of acidic tail removal but to a lesser extent thus demonstrating that in vivo acetylated HMGB1 is capable of modulating its interaction with negatively supercoiled DNA.

Indexed as

Protein Processing, Post-TranslationalAcetylationButyratesDNA, SuperhelicalDNA Topoisomerases, Type IHMGB1 ProteinHumansLysineProtein BindingTumor Cells, CulturedButyratesDNA, SuperhelicalDNA Topoisomerases, Type IHMGB1 ProteinLysine

Identifiers

PMID18670905
OpenAlexW2007040683

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.